Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Big Data and Trustworthy AI for Heart Failure: A Review
0
Zitationen
13
Autoren
2026
Jahr
Abstract
The rapid evolution of machine learning techniques, combined with the growing availability of large and diverse data sets, is poised to transform heart failure research and clinical care. This review first provides an overview of key machine learning and artificial intelligence concepts used in heart failure research and then examines how diverse data modalities-including electronic health records, patient registries, biobanks, imaging, telemonitoring, and synthetic data-are leveraged to develop machine learning applications for heart failure diagnosis, prognosis, risk stratification, and personalized treatment strategies. While the potential is considerable, we highlight key barriers to clinical translation, such as data heterogeneity, algorithmic bias, lack of interoperability, and privacy concerns. The review also examines the need for explainable and equitable artificial intelligence systems and evaluates emerging solutions, including Federated Learning and synthetic data generation to address fairness and data privacy challenges. Beyond technical innovations, we underscore the importance of human-centered design, stakeholder engagement, and regulatory readiness. We conclude by identifying future priorities and calling for interdisciplinary collaboration to ensure the scalable, ethical, and effective integration of AI in heart failure management.
Ähnliche Arbeiten
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
2021 · 19.544 Zit.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.685 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.619 Zit.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 · 11.735 Zit.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
2002 · 11.655 Zit.
Autoren
Institutionen
- Universitat de Barcelona(ES)
- University of Oxford(GB)
- Universidad Autónoma de Madrid(ES)
- Universidad Politécnica de Madrid(ES)
- Heart Rhythm Society(US)
- Amsterdam University Medical Centers(NL)
- University of Amsterdam(NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)
- Information Technologies Institute(GR)
- National Institute for Health and Care Research(GB)
- Health Data Research UK(GB)
- University College London(GB)
- Institució Catalana de Recerca i Estudis Avançats(ES)